Recent Updates
Recently added Catalysts
ATHE Neutral Sentiment Score: 45/100

Market Announcement 4 September 2025 Alterity Therapeutics Limited (ASX: ATH) - Trading Halt Trading in the securities of Alterity Therapeutics Limited ( ATH') will be halted at the request of ATH, pending the release of

Key Takeaway: Alterity Therapeutics Limited has requested a trading halt for its securities at the Australian Securities Exchange (ASX) pending the announcement of significant information. The trading halt will remain in effect unless ASX decides otherwise, potentially impacting investor sentiment. Details regarding the nature of the anticipated announcement remain undisclosed, leading to uncertainty in the market regarding the company's future actions.

Market Sentiment Analysis

CONCERNS & RISKS

  • Trading halted due to unspecified upcoming announcement, creating uncertainty.
  • Potential negative market reaction to the cause of the trading halt.

Full Press Release Details

Alterity Therapeutics Limited (ASX: ATH) - Trading
Trading in the securities of Alterity
Therapeutics Limited ( ATH') will be halted at the request of ATH, pending the release of an announcement by ATH.
Unless ASX decides otherwise, the securities will remain
in trading halt until the earlier of:
ATH's request for a trading halt is attached below
for the information of the market.
4 September 2025 Market Announcement 1/1
ASX Limited ASX Customer Service Centre 131 279 | asx.com.au
Adviser, Listings Compliance (Melbourne) ASX Limited
Request for a trading halt
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the
Company), requests that the Company's securities be placed into a trading halt with immediate effect.
For the purposes of Listing Rule 17.1, the Company provides
the following information:
Please contact us should you have any questions.
/s/ Abby Macnish Niven
Abby Macnish Niven
Company Secretary
For and on behalf of the Board of Alterity Therapeutics
Alterity Therapeutics Limited
Suite 4, Level 14, 350 Collins Street, Melbourne,
T: +61 (0)3 9349 4906 | www.alteritytherapeutics.com

Frequently Asked Questions

Why is trading halted for Alterity Therapeutics?

Trading in Alterity Therapeutics is halted at the company's request pending an announcement.

When will the trading halt for ATH end?

The trading halt will continue until the company requests to lift it or ASX decides otherwise.

What is the official contact for trading halt inquiries?

Inquiries can be directed to Abby Macnish Niven, the Company Secretary.

What date did the trading halt for ATH begin?

The trading halt for Alterity Therapeutics began on 4 September 2025.

How can I reach Alterity Therapeutics for more information?

You can contact Alterity Therapeutics through their website or by phone.

Last updated: Sep 4, 2025